With the precision of monoclonal antibodies and the potency of small-molecular payloads, antibody-drug conjugates (ADC) are promising cancer therapeutics. As of this year, there are 19 ADC drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback